Incyte (INCY) Return on Capital Employed Growth (5y) (2016 - 2026)
Incyte (INCY) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn |
| 10 | Incyte | 23.81 Bn | 19.80 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,176.00 |
| Dec 31, 2025 | 3,894.00 |
| Sep 30, 2025 | 4,380.00 |
| Jun 30, 2025 | 3,466.00 |
| Mar 31, 2025 | 1,750.00 |
| Dec 31, 2024 | -2,951.00 |
| Sep 30, 2024 | -2,882.00 |
| Jun 30, 2024 | -1,116.00 |
| Mar 31, 2024 | 78.00 |
| Dec 31, 2023 | 562.00 |
| Sep 30, 2023 | 1,328.00 |
| Jun 30, 2023 | 1,385.00 |
| Mar 31, 2023 | 1,935.00 |
| Dec 31, 2022 | 2,522.00 |
| Sep 30, 2022 | 1,815.00 |
| Jun 30, 2022 | 2,147.00 |
| Mar 31, 2022 | 1,654.00 |
| Dec 31, 2021 | 478.00 |
| Sep 30, 2021 | 770.00 |
| Jun 30, 2021 | -61.00 |